145 related articles for article (PubMed ID: 23392415)
1. A comparison of patients who have undergone 1-Level versus 2-Level ProDisc arthroplasty: a prospective study with minimum of 5-year follow-up.
Yue J; Zhang K; Bai HX; Du J; Cammisa F; Abjornson C; Mo F
Spine (Phila Pa 1976); 2013 Jun; 38(14):1194-8. PubMed ID: 23392415
[TBL] [Abstract][Full Text] [Related]
2. Results of the prospective, randomized, multicenter Food and Drug Administration investigational device exemption study of the ProDisc-L total disc replacement versus circumferential fusion for the treatment of 1-level degenerative disc disease.
Zigler J; Delamarter R; Spivak JM; Linovitz RJ; Danielson GO; Haider TT; Cammisa F; Zuchermann J; Balderston R; Kitchel S; Foley K; Watkins R; Bradford D; Yue J; Yuan H; Herkowitz H; Geiger D; Bendo J; Peppers T; Sachs B; Girardi F; Kropf M; Goldstein J
Spine (Phila Pa 1976); 2007 May; 32(11):1155-62; discussion 1163. PubMed ID: 17495770
[TBL] [Abstract][Full Text] [Related]
3. ProDisc-L total disc replacement: a comparison of 1-level versus 2-level arthroplasty patients with a minimum 2-year follow-up.
Hannibal M; Thomas DJ; Low J; Hsu KY; Zucherman J
Spine (Phila Pa 1976); 2007 Oct; 32(21):2322-6. PubMed ID: 17906573
[TBL] [Abstract][Full Text] [Related]
4. Prospective, randomized, multicenter Food and Drug Administration investigational device exemption study of lumbar total disc replacement with the CHARITE artificial disc versus lumbar fusion: five-year follow-up.
Guyer RD; McAfee PC; Banco RJ; Bitan FD; Cappuccino A; Geisler FH; Hochschuler SH; Holt RT; Jenis LG; Majd ME; Regan JJ; Tromanhauser SG; Wong DC; Blumenthal SL
Spine J; 2009 May; 9(5):374-86. PubMed ID: 18805066
[TBL] [Abstract][Full Text] [Related]
5. Results of the prospective, randomized, controlled multicenter Food and Drug Administration investigational device exemption study of the ProDisc-C total disc replacement versus anterior discectomy and fusion for the treatment of 1-level symptomatic cervical disc disease.
Murrey D; Janssen M; Delamarter R; Goldstein J; Zigler J; Tay B; Darden B
Spine J; 2009 Apr; 9(4):275-86. PubMed ID: 18774751
[TBL] [Abstract][Full Text] [Related]
6. ProDisc-C and anterior cervical discectomy and fusion as surgical treatment for single-level cervical symptomatic degenerative disc disease: five-year results of a Food and Drug Administration study.
Zigler JE; Delamarter R; Murrey D; Spivak J; Janssen M
Spine (Phila Pa 1976); 2013 Feb; 38(3):203-9. PubMed ID: 23080427
[TBL] [Abstract][Full Text] [Related]
7. Prospective, randomized, multicenter Food and Drug Administration investigational device exemption study of the ProDisc-L total disc replacement compared with circumferential arthrodesis for the treatment of two-level lumbar degenerative disc disease: results at twenty-four months.
Delamarter R; Zigler JE; Balderston RA; Cammisa FP; Goldstein JA; Spivak JM
J Bone Joint Surg Am; 2011 Apr; 93(8):705-15. PubMed ID: 21398574
[TBL] [Abstract][Full Text] [Related]
8. Lumbar disc arthroplasty with Maverick disc versus stand-alone interbody fusion: a prospective, randomized, controlled, multicenter investigational device exemption trial.
Gornet MF; Burkus JK; Dryer RF; Peloza JH
Spine (Phila Pa 1976); 2011 Dec; 36(25):E1600-11. PubMed ID: 21415812
[TBL] [Abstract][Full Text] [Related]
9. Clinical and radiographic analysis of an artificial cervical disc: 7-year follow-up from the Prestige prospective randomized controlled clinical trial: Clinical article.
Burkus JK; Traynelis VC; Haid RW; Mummaneni PV
J Neurosurg Spine; 2014 Oct; 21(4):516-28. PubMed ID: 25036218
[TBL] [Abstract][Full Text] [Related]
10. Five-year results of the prospective, randomized, multicenter, Food and Drug Administration investigational device exemption study of the ProDisc-L total disc replacement versus circumferential arthrodesis for the treatment of single-level degenerative disc disease.
Zigler JE; Delamarter RB
J Neurosurg Spine; 2012 Dec; 17(6):493-501. PubMed ID: 23082846
[TBL] [Abstract][Full Text] [Related]
11. ProDisc-C Total Disc Replacement Versus Anterior Cervical Discectomy and Fusion for Single-Level Symptomatic Cervical Disc Disease: Seven-Year Follow-up of the Prospective Randomized U.S. Food and Drug Administration Investigational Device Exemption Study.
Janssen ME; Zigler JE; Spivak JM; Delamarter RB; Darden BV; Kopjar B
J Bone Joint Surg Am; 2015 Nov; 97(21):1738-47. PubMed ID: 26537161
[TBL] [Abstract][Full Text] [Related]
12. Factors affecting reoperations after anterior cervical discectomy and fusion within and outside of a Federal Drug Administration investigational device exemption cervical disc replacement trial.
Singh K; Phillips FM; Park DK; Pelton MA; An HS; Goldberg EJ
Spine J; 2012 May; 12(5):372-8. PubMed ID: 22425784
[TBL] [Abstract][Full Text] [Related]
13. Clinical outcome of lumbar total disc replacement using ProDisc-L in degenerative disc disease: minimum 5-year follow-up results at a single institute.
Park CK; Ryu KS; Lee KY; Lee HJ
Spine (Phila Pa 1976); 2012 Apr; 37(8):672-7. PubMed ID: 21857395
[TBL] [Abstract][Full Text] [Related]
14. Comparison of 2 lumbar total disc replacements: results of a prospective, randomized, controlled, multicenter Food and Drug Administration trial with 24-month follow-up.
Guyer RD; Pettine K; Roh JS; Dimmig TA; Coric D; McAfee PC; Ohnmeiss DD
Spine (Phila Pa 1976); 2014 May; 39(12):925-31. PubMed ID: 24718066
[TBL] [Abstract][Full Text] [Related]
15. The treatment of disabling multilevel lumbar discogenic low back pain with total disc arthroplasty utilizing the ProDisc prosthesis: a prospective study with 2-year minimum follow-up.
Bertagnoli R; Yue JJ; Shah RV; Nanieva R; Pfeiffer F; Fenk-Mayer A; Kershaw T; Husted DS
Spine (Phila Pa 1976); 2005 Oct; 30(19):2192-9. PubMed ID: 16205346
[TBL] [Abstract][Full Text] [Related]
16. Lumbar total disc arthroplasty in patients older than 60 years of age: a prospective study of the ProDisc prosthesis with 2-year minimum follow-up period.
Bertagnoli R; Yue JJ; Nanieva R; Fenk-Mayer A; Husted DS; Shah RV; Emerson JW
J Neurosurg Spine; 2006 Feb; 4(2):85-90. PubMed ID: 16506473
[TBL] [Abstract][Full Text] [Related]
17. A prospective, randomized, controlled clinical investigation comparing PCM cervical disc arthroplasty with anterior cervical discectomy and fusion. 2-year results from the US FDA IDE clinical trial.
Phillips FM; Lee JY; Geisler FH; Cappuccino A; Chaput CD; DeVine JG; Reah C; Gilder KM; Howell KM; McAfee PC
Spine (Phila Pa 1976); 2013 Jul; 38(15):E907-18. PubMed ID: 23591659
[TBL] [Abstract][Full Text] [Related]
18. Cervical total disc replacement with the Mobi-C cervical artificial disc compared with anterior discectomy and fusion for treatment of 2-level symptomatic degenerative disc disease: a prospective, randomized, controlled multicenter clinical trial: clinical article.
Davis RJ; Kim KD; Hisey MS; Hoffman GA; Bae HW; Gaede SE; Rashbaum RF; Nunley PD; Peterson DL; Stokes JK
J Neurosurg Spine; 2013 Nov; 19(5):532-45. PubMed ID: 24010901
[TBL] [Abstract][Full Text] [Related]
19. Clinical outcomes with selectively constrained SECURE-C cervical disc arthroplasty: two-year results from a prospective, randomized, controlled, multicenter investigational device exemption study.
Vaccaro A; Beutler W; Peppelman W; Marzluff JM; Highsmith J; Mugglin A; DeMuth G; Gudipally M; Baker KJ
Spine (Phila Pa 1976); 2013 Dec; 38(26):2227-39. PubMed ID: 24335629
[TBL] [Abstract][Full Text] [Related]
20. The treatment of disabling single-level lumbar discogenic low back pain with total disc arthroplasty utilizing the Prodisc prosthesis: a prospective study with 2-year minimum follow-up.
Bertagnoli R; Yue JJ; Shah RV; Nanieva R; Pfeiffer F; Fenk-Mayer A; Kershaw T; Husted DS
Spine (Phila Pa 1976); 2005 Oct; 30(19):2230-6. PubMed ID: 16205353
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
